Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C (FIX-HF-5C)
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Sponsor: Impulse Dynamics
Listed as NCT01381172, this NA trial focuses on NYHA Class III Heart Failure and NYHA Class IV Heart Failure and remains completed. Sponsored by Impulse Dynamics, it has been updated 15 times since 2011, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Oct 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — Mar 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Mar 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Oct 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Mar 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Mar 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Impulse Dynamics
For direct contact, visit the study record on ClinicalTrials.gov .